Cochrane Abstracts
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/Interferon_alpha_for_chronic_hepatitis_D_New. Accessed 16 April 2024.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/Interferon_alpha_for_chronic_hepatitis_D_New. Accessed April 16, 2024.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/Interferon_alpha_for_chronic_hepatitis_D_New
Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors [Internet]. In: Cochrane Abstracts. [cited 2024 April 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/Interferon_alpha_for_chronic_hepatitis_D_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
ID - 435846
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/0/Interferon_alpha_for_chronic_hepatitis_D_New
DB - Evidence Central
DP - Unbound Medicine
ER -
